What does CUSIP 55279B202 represent in this 13F holders report?

CUSIP 55279B202 is the security identifier for MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value used to aggregate holder disclosures.

How many institutions held MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value in Q2 2018?

57 institutional investors reported MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value for Q2 2018. Use the holders table for investor-level position and value details.

MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)

CUSIP: 55279B202

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock, $0.00000002 par value
Shares outstanding: 29,545,622
Total 13F shares: 36,391,138
Share change: +27,876,559
Total reported value: $143,378,000
Put/Call ratio: 1.6%
Price per share: $3.94
Number of holders: 57
Value change: +$111,542,358
Number of buys: 37
Number of sells: 21

Security key

55279B202

Report period

Q2 2018

Institutions

Top holders

MEIP full security history Newer quarter: Q3 2018 Previous quarter: Q1 2018 Lite Strategy, Inc. SEC filings Lite Strategy, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 55279B202

Newer quarter: Q3 2018 Previous quarter: Q1 2018

Recent filing periods:

Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021

Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RENAISSANCE TECHNOLOGIES LLC	13F	Company	6.4%	1,891,313	$3,915,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	4.9%	1,461,211	$3,025,000	—	31 Mar 2018	13F
Sio Capital Management, LLC	13F	Company	3.2%	934,563	$1,935,000	—	31 Mar 2018	13F
BlackRock Finance, Inc.	13F	Company	1.7%	488,727	$1,012,000	—	31 Mar 2018	13F
AJO, LP	13F	Company	1.5%	438,710	$908,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.5%	428,592	$887,000	—	31 Mar 2018	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	1.4%	428,136	$886,000	—	31 Mar 2018	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	1.2%	368,050	$762,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.77%	226,980	$470,000	—	31 Mar 2018	13F
ClariVest Asset Management LLC	13F	Company	0.7%	206,600	$428,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.69%	204,136	$422,000	—	31 Mar 2018	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.62%	183,447	$380,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.61%	180,213	$373,000	—	31 Mar 2018	13F
Ancora Advisors LLC	13F	Company	0.57%	167,462	$347,000	—	31 Mar 2018	13F
Russell Investments Group, Ltd.	13F	Company	0.41%	122,259	$253,000	—	31 Mar 2018	13F
Walleye Trading LLC	13F	Company	0.36%	106,942	$221,000	—	31 Mar 2018	13F
ALGERT GLOBAL LLC	13F	Company	0.34%	100,140	$207,000	—	31 Mar 2018	13F
WITTENBERG INVESTMENT MANAGEMENT, INC.	13F	Company	0.23%	68,399	$142,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.23%	67,281	$139,000	—	31 Mar 2018	13F
NATIXIS	13F	Company	0.17%	50,000	$104,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.15%	45,385	$94,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.15%	45,128	$94,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.12%	36,600	$76,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.1%	30,544	$64,000	—	31 Mar 2018	13F
Transform Wealth, LLC	13F	Company	0.1%	30,355	$63,000	—	31 Mar 2018	13F
BB&T SECURITIES, LLC	13F	Company	0.1%	28,700	$59,000	—	31 Mar 2018	13F
A.R.T. Advisors, LLC	13F	Company	0.09%	25,369	$52,000	—	31 Mar 2018	13F
Federation Des Caisses Desjardins du Quebec	13F	Individual	0.08%	23,713	$49,115	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.06%	17,367	$36,000	—	31 Mar 2018	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.06%	16,331	$34,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.05%	15,500	$32,000	—	31 Mar 2018	13F
David M. Knott	13F	Individual	0.05%	14,000	$29,000	—	31 Mar 2018	13F
Squarepoint Ops LLC	13F	Company	0.04%	12,500	$26,000	—	31 Mar 2018	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.04%	12,235	$25,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.04%	10,553	$22,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	5,007	$10,000	—	31 Mar 2018	13F
Sargent Bickham Lagudis LLC	13F	Company	0.01%	3,150	$7,000	—	31 Mar 2018	13F
Cutler Group LLC / CA	13F	Company	0.01%	2,550	$5,000	—	31 Mar 2018	13F
QS Investors, LLC	13F	Company	0.01%	2,360	$5,000	—	31 Mar 2018	13F
SIGNET FINANCIAL MANAGEMENT, LLC	13F	Company	0.01%	2,000	$4,000	—	31 Mar 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,063	$2,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0%	1,008	$2,000	—	31 Mar 2018	13F
ROYAL BANK OF CANADA	13F	Company	0%	650	$1,000	—	31 Mar 2018	13F

Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2018

As of 30 Jun 2018, MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by 57 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,391,138 shares. The largest 10 holders included Vivo Capital, LLC, NEA Management Company, LLC, CAXTON CORP, BVF INC/IL, BOXER CAPITAL, LLC, RENAISSANCE TECHNOLOGIES LLC, Sio Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, and ACUTA CAPITAL PARTNERS, LLC. This page lists 57 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

Q2 2018 holders

Holder diff

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.